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ABSTRACT 
 
 
 
 
      
 Incorporation of nanoparticles in drug vehicle has attracted much attention in 
the area of drug delivery application due to its unique properties. It is hypothesised 
graphene oxide (GO) nanoparticles incorporation can provide excellent hydrogel 
properties with effective drug vehicle. In this work, GO nanoparticles are used in the 
formulation of floating hydrogel prepared using κ-carrageenan, sodium 
carboxymethyl cellulose and calcium carbonates. Calcium carbonate is added as 
effervescent agents to promote the buoyancy effect. Floating hydrogel without GO 
nanoparticle and floating hydrogel with GO nanoparticle act as controls. The 
analyses were carried out on swelling degree, antibacterial study, floating properties 
and in vitro methylene blue released as modelled drug. The properties of drug carrier 
were analysed using Fourier transform infrared spectroscopy (FTIR), TGA and 
Variable Pressure Scanning Electron Microscope (VPSEM). GO-loaded floating 
nanocomposite hydrogels showed significant effect on swelling ratio which is 
reduced more than 50% but did not much effect on kinetic reaction with acidic pH1.2 
buffer solution. Antibacterial properties were proved based on positive result that 
inhibited spore growth within 96hours. In vitro released profile with additional 
0.01% GO was slower (5.4%) compared to the controls. In summary, GO 
nanoparticles-loaded κ-carrageenan based floating nanocomposite hydrogel has a 
significant floating potential that could be used as prospective drug carrier in 
gastrointestinal tract.   
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ABSTRAK 
 
 
 
 
Campuran nanopartikel dalam sistem penyampaian dadah telah menarik 
banyak perhatian dalam bidang aplikasi penghantaran ubat kerana sifatnya yang 
unik. Ia adalah hipotesis graphene oxide (GO) nanopartikel yang dicampur boleh 
memberikan sifat hidrogel yang sangat baik dengan penyampaian ubat yang 
berkesan. Dalam kerja ini, nanopartikel GO digunakan dalam perumusan hidrogel 
terapung yang disediakan menggunakan κ-carrageenan, natrium karboksimetil 
selulosa dan kalsium karbonat. Kalsium karbonat ditambah sebagai ejen ampungan 
untuk mempromosikan kesan keapungan. Hidrogel terapung tanpa GO nanoparticle 
dan hydrogel terapung dengan GO nanoparticle bertindak sebagai kawalan. Analisis 
dilakukan pada tahap serapan air, kajian antibakteria, sifat-sifat terapung dan in vitro 
metilene biru dilepaskan sebagai ubat model. Ciri-ciri pembawa dadah dianalisa 
menggunakan spektroskopi inframerah transformasi Fourier (FTIR), TGA dan 
Mikroskop Pengimbasan Tekanan Pembolehubah (VPSEM). Hidrogel nanocomposit 
terapung yang dicampur GO menunjukkan kesan yang ketara terhadap nisbah 
serapan air yang berkurang lebih daripada 50% tetapi tidak banyak memberi kesan 
kepada tindak balas kinetik dengan redaman pH1.2 berasid. Sifat antibakteria 
terbukti berdasarkan hasil positif yang menghalang pertumbuhan spora dalam 
tempoh 96 jam. Profil in vitro yang dikeluarkan dengan tambahan 0.01% GO adalah 
perlahan (5.4%) berbanding dengan kawalan. Ringkasnya, GO nanopartikel yang 
dimuatkan κ-carrageenan berasaskan nanocomposite terapung hidrogel mempunyai 
potensi terapung yang besar yang boleh digunakan sebagai pembawa dadah 
prospektif dalam saluran gastrointestinal. 
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Research Background  
 
 
Hydrogel is a macromolecular polymer gel that was constructed of network 
of crosslinked polymer chain. Due to their properties like hydrophilic, 
biocompatibility and three dimensional structures, hydrogel especially “smart” 
hydrogel became the great interest to biomaterials scientists. According to Ebara and 
co-workers(2014),“Smart hydrogel” has the remarkable ability to respond to stimuli 
in a variety of ways. It has enormous potential in various biomedical applications 
because some environmental variables, such as low pH and elevated temperatures are 
found in the human body which is important factor need to consider in designing 
drug delivery system (Jingquanet al., 2014). The fascinating properties of the 
stimuli-sensitive polymers are promising for many future applications and offer 
possible use as the next generation of materials in biological, biomedical and 
pharmaceutical products.  
 
 
The hydrogel can be classified in various physical form including solid model 
form (e.g. soft contact lenses), pressed powder matrices (e.g. pills or capsules for oral 
ingestion), microparticles (e.g. as bioadhesivecarriersfor wound treatments),coating
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 (e.g. on implants or catheters on pills or capsule or coating on the inside 
capillaryelectrophoresis), membranes or sheets (e.g. as reservoir in a transdermal 
drug delivery patch), encapsulated solids (e.g. osmotic pumps) and liquids form (e.g. 
gels upon heating or cooling) (Ebaraet al., 2014; Hoffman, 2002).  
 
 
Despite considerable advancements in drug delivery, the oral route remains 
the preferred route due to ease of administration and a cheaper therapy compare to 
other route. However, the main important is to achieve the high level of patient 
compliance.  
 
 
Recently, there are many researches on the development of new materials and 
these partly are the innovative combination of known components. The structural 
combination of a polymer hydrogel network with nanoparticles (metals, non-metals 
and metal oxides) promising of providing superior functionality to the composite 
materials with various applications (Praveenet al,. 2015) The new components could 
be applied in diverse fields including catalysis, electronics, bio-sensing, drug 
delivery, nano-medicine, and environmental remediation. Today, incorporation with 
nanoparticle hydrogel finds their applications in common consumer products and 
appliances due to their differences in properties compared to bulk materials. 
However, Praveen and his coworker (2015) stated that, the hydrogel with 
nanoparticles still have challenges to decrease risks to human health and 
environment.  
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1.2 Problem Statement 
 
 
Recently, many people are aware and concern about their health. The modern 
lifestyle such as over taking junk food, fast food and the food that contain high 
percentage of saturated fats are the major factors of unhealthy lifestyle. These 
imbalance diets will cause the body prone to diseases such as diabetes, heart problem 
and cancer (Rajgopalet al., 2002). Therefore the patient will seekthe most effective 
medicine that can reduce pain and heal as fastas possible.  
 
 
In conventional dosage form, oral drugs delivery are easily absorbed into 
gastrointestinal tract and have a short-lives due to quickly eliminated from systemic 
circulation. Frequent dosing is required to achieve suitable therapeutic activity. 
Sometime, the drugs carried by drug vehicle could not deliver directly to specific 
target of action to achieve and maintain the desired drug concentration in the body. 
 
 
By taking conventional oral dosage, patients need to follow the instruction 
and advice from doctor or medical expertisein hospital. Sometimes the patients 
forget to follow the schedule by taking the medicine on time or lazy to consume it 
frequently per day. This is because the conventional oral dosage forms suffer from 
inability of drug to reside in stomach or proximal part of the small intestine for a 
prolonged period (Singh and Chauhan.,2011). These will result incomplete drug 
release in the absorption zone and reducing its bioavailability and therapeutic 
efficacy (Gadadet al., 2009). In another words, the conventional dosage form is very 
wasting because of incomplete absorption and reduce patient’s compliance to 
consume it (Sing et al., 2011).  
 
 
Other factors that lead to unhealthy styles are poor sleeping habit, smoking 
and alcoholic addiction. These bad habits contribute stress to the body and may 
reduce the absorption nutrient into the body (Nicklaset al., 2000). Insufficient 
nutrient in the body may cause the person to easily feel tired, inactive and promote 
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sickness and diseases (Nicklaset al., 2001). To overcome this problem, many people 
take some dietary supplements of essential nutrient such as vitamin, calcium, iron 
and probiotics to replenishthe lack of nutrient in the body (Nicklaset al., 2001).  
 
 
Oral controlled-release drug delivery system provide drug release at a 
predetermined, predictable, and controlled rate and have drawn considerable 
attention. Moreover, some drugs have demonstrated poor bioavailability and 
biocompatibility due to incomplete absorption or degradation in gastrointestinal tract. 
Biocompatibility is the major concern in development of biomaterial (Ying et al., 
2013). 
 
 
 Based onthese problems, more effective way of therapeutic drug or functional 
food deliveryinto the body has to be studied. To achieve the desired concentration of 
drug or essential nutrient absorbs into the blood or tissue, designing drug delivery 
system need to be improved (Singh et al., 2011). Floating deliveryis one of the 
systems than could potentiallyachieve longer retention time of capsulated bioactive 
drug or functional food in the gastrointestinal tract (Rajinikhanth and Mishra, 2008). 
This system will enhance the absorbance of drug or functional food. At the same 
time, the patient can reduce uptake of oral drug dose per day due the longer 
pharmacotherapy per dose intake (Patilet al., 2011). 
 
 
To avoid this limitation, extensive research need to be carried out in 
designing of sustained drug delivery system that can highly control the drug release, 
so the drug could be supplied continuously to its absorption site in gastrointestinal 
tract.Efficient drug delivery system is crucial to ensure optimum dosage of medicine 
necessary to treat a certain disease. Taking over dosage or drug that is wasted in the 
digestive system will reduce the benefit to the patients. Hence, a more effective 
design of delivery system will help patient to heal in a comfortable and practical 
way. 
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To improve targeted delivery of drug, the bioavailability and stability of 
therapeutic agents against degradation and extending drug effect in target tissue, 
applying nanoparticles seemsto offer much benefit in pharmaceutical studies 
(Hezaveh and Muhammad, 2012). Besides, applied nanotechnology in drug delivery 
system offers a suitable method for site-specific and time-controlled delivery of 
bioactive agents. Many biomaterial researchers showed interests to develop  hydrogel 
incorporated with nanoparticles like gold nanoparticle, graphene, graphene oxide and 
magnesium oxide for this purpose.  
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1.3 Objectives of Study 
 
 
 To develop carrageenan based floating hydrogel incorporated with graphene 
oxide and evaluateits performance in drug delivery system.  
 
 
 
 
 
1.4 Scope of Study 
 
 
 To achieve the objective, three scopes have been identified in this study 
 
(1) Formulations of carrageenan based floating hydrogel with graphene oxide 
and examinethe effect of blend ratio by measuringthe swelling degree of 
hydrogel.  
 
(2) Determination of drug release properties by evaluatingdrug release 
profilesoffloating hydrogel incorporated with graphene oxide and floating 
hydrogel withoutgraphene oxide. 
 
(3) Study of the properties offloating carrageenan based hydrogel incorporated 
with graphene oxide based on antimicrobialeffect, surface morphology 
thermal stability. 
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